Genmab A/S
GMAB
$22.25
$0.050.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.51% | 194.55% | -8.17% | 5.81% | 89.19% |
| Total Depreciation and Amortization | -2.65% | -0.42% | -30.26% | 82.03% | 55.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.54% | -207.27% | 91.12% | 293.41% | -139.04% |
| Change in Net Operating Assets | 837.13% | 110.36% | 22.33% | -262.98% | 448.76% |
| Cash from Operations | -25.95% | 29.38% | 37.23% | -0.31% | -9.27% |
| Capital Expenditure | 10.67% | -139.91% | -43.73% | 2.61% | 58.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -223.25% | -34.85% | -92.36% | 345.22% | -280.52% |
| Cash from Investing | -466.93% | -64.50% | 102.61% | -502.72% | -229.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 10.53% | -533.33% | 88.00% |
| Issuance of Common Stock | -90.91% | -74.42% | 168.75% | 77.78% | 0.00% |
| Repurchase of Common Stock | -50.00% | 97.35% | 90.09% | -3,249.45% | -1,416.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3,132.42% | 101.05% | 90.76% | -417.92% | -2,576.32% |
| Foreign Exchange rate Adjustments | -92.21% | 2,224.41% | 205.65% | -318.44% | 98.87% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -52.44% | 69.57% | 119.86% | -1,837.42% | -189.79% |